GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Osi Pharmaceuticals Inc. (OSIP) [hlAlert]

OSI Pharmaceuticals, Inc. (OSI) is a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing unmet medical needs in oncology, diabetes and obesity. The Company's primary focus is oncology and its flagship product is Tarceva (erlotinib), a small
molecule inhibitor of the epidermal growth factor receptor (EGFR). OSI also has research and development programs in diabetes and obesity, which are conducted through Prosidion Limited, the Company's United Kingdom subsidiary. Roche Holding Ltd. and OSI announced that Tarceva (erlotinib) has been approved in Japan for the treatment of patients with nonresectable, recurrent and advanced non-small cell lung cancer (NSCLC), which is aggravated following chemotherapy. In December 2008, the Company acquired from 7TM Pharma A/S, a number of early stage research assets and a G-Protein coupled receptor (GPCR), technology platform.
.
( Total: 17 Current Stock Recommendations )
Osi Pharmaceuticals Inc.   (17)
Hold 53% Buy 47%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Hold OSIP
up 68.48 %
Osi Pharmaceuticals Inc. (OSIP) downgraded to Neutral by UBS
Tuesday,  Mar 2, 2010  8:25 AM ET

Rating:
Hold OSIP
up 43.37 %

Rating:
Buy OSIP
up 89.03 %

Rating:
Hold OSIP

Rating:
None
Osi Pharmaceuticals Inc. (OSIP) rated Perform by Oppenheimer
Friday,  Jun 19, 2009  8:25 AM ET

Rating:
Hold OSIP

Rating:
Hold OSIP

Rating:
Hold OSIP

Rating:
Buy OSIP
up 68.48 %

Rating:
Buy OSIP
up 43.37 %

Rating:
Buy OSIP
down 22.01 %

Rating:
Buy OSIP
down 21.04 %

Rating:
Hold OSIP
Osi Pharmaceuticals Inc. (OSIP) rated Neutral by Cowen & Co
Tuesday,  Nov 18, 2008  9:25 AM ET

Rating:
Buy OSIP
down 25.04 %

Your Recent Stocks
SymbolLastChange
OSIP 57.49 up  85.09 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy